Follow The Filings

ALEC Alector Inc.

Health Care, filed as ALECTOR INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.4%
  • $1.8M

Who owns this now

Largest portfolio weights among holders, up to 0.4% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel 0.35%

Who owns ALEC

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 0.35% Hold 908,351 $1.8M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by ALEC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ALEC insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $48K sold by 1 insider under 10b5-1 plans
  1. Grace Wong-Sarad Principal Accounting Officer
    Planned sale
    $11K 4,281 shares at $2.55 3.9% of stake
    Traded Sep 2–4 Filed Sep 4
    ↗
  2. Grace Wong-Sarad Principal Accounting Officer
    Planned sale
    $6,543 3,475 shares at $1.88 3.5% of stake
    Traded Jun 3 Filed Jun 3
    ↗
  3. Grace Wong-Sarad Principal Accounting Officer
    Planned sale
    $4,823 1,820 shares at $2.65 1.7% of stake
    Traded Apr 16 Filed Apr 17
    ↗
  4. Grace Wong-Sarad Principal Accounting Officer
    Planned sale
    $2,650 1,000 shares at $2.65 0.9% of stake
    Traded Mar 10 Filed Mar 12
    ↗
  5. Grace Wong-Sarad Principal Accounting Officer
    Planned sale
    $7,012 3,367 shares at $2.08 3% of stake
    Traded Mar 3 Filed Mar 3
    ↗
  6. Grace Wong-Sarad Principal Accounting Officer
    Planned sale
    $10K 4,079 shares at $2.50 3.3% of stake
    Traded Feb 26 Filed Feb 26
    ↗
  7. Grace Wong-Sarad Principal Accounting Officer
    Planned sale
    $5,751 4,753 shares at $1.21 3.7% of stake
    Traded Dec 5, 2025 Filed Dec 8, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 stock grants, 13 sales to cover taxes, and 4 gifts.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 1.01,2.02,7.01,8.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.02 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $97.06M $100.56M $21.04M
Net income -$130.39M -$119.05M -$142.93M
Net margin * -134.3% -118.4% -679.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $565.81M $424.82M $266.45M
Total non-current assets * $56.02M $43.49M $26.78M
Total assets $621.83M $468.3M $293.24M
Total current liabilities $177.95M $125.06M $69.5M
Total non-current liabilities * $309.72M $216.44M $193.08M
Total equity $134.16M $126.8M $30.65M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$184.16M -$229.9M -$184.03M
Cash from investing $101.92M $107.13M $196.6M
Cash from financing $2.55M $81.54M $20.22M
Net change in cash -$79.69M -$41.23M $32.78M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.